What is POAI's earnings growth forecast for 2025-2025?
(NASDAQ: POAI) Predictive Oncology's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 15.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Predictive Oncology's earnings in 2025 is -$10,888,418.
In 2025, POAI is forecast to generate -$1,161,111 in earnings, with the lowest earnings forecast at -$1,161,111 and the highest earnings forecast at -$1,161,111.
What is POAI's forecast return on equity (ROE) for 2025-2028?
(NASDAQ: POAI) forecast ROE is -2,818.01%, which is considered weak.
What is POAI's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: POAI) Predictive Oncology's current Earnings Per Share (EPS) is -$1.74. In 2025, POAI's EPS is forecast to hit -$0.13 (min: -$0.13, max: -$0.13).
What is POAI's forecast return on assets (ROA) for 2025-2028?
(NASDAQ: POAI) forecast ROA is 70.01%, which is higher than the forecast US Medical Instruments & Supplies industry average of 5.33%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.